Position in UPB
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$259,776
New position
Shares Held
28,864
first reported quarter
Ownership
0.053%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bleakley Financial Group, LLC holds $17,422,210 across 16 Biotechnology names. UPB ranks #14 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,226 | $7,692,098 | |
| 2 | ANAB |
Anaptysbio, Inc
|
43,120 | $2,391,433 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
12,802 | $1,349,330 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
163,572 | $1,254,597 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
14,316 | $1,074,988 | |
| 6 | BCAX |
Bicara Therapeutics Inc.
|
29,331 | $583,393 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,967 | $526,086 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
11,628 | $386,282 |
All Filings in UPB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $259,776 | 28,864 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||